1-20 of 513 results for subject:Antimicrobials
Librarians' tools
- Search time
- 0.453 seconds
- Solr query time
- 0.004 seconds
- Search query
- subject:Antimicrobials
- We searched for
- subject_t:Antimicrobials OR subject_ses:456232
Type
House
Session
Year
Department
More
Member
More
Primary member
More
Answering member
More
Legislative stage
Legislation
Subject
More
Publisher
To ask the Secretary of State for Health and Social Care, pursuant to the Answer of 11 June 2026 to Written Question 7918 on Antimicrobials, whether the expected timetable for contract award under the UK antimicrobial subscription model remains November 2026; and whether the Department is able to share a...
To ask the Secretary of State for Health and Social Care, pursuant to the Answer of 11 June 2026 to Written Question 7918 on Antimicrobials, whether the expected timetable for contract award under the UK antimicrobial subscription model remains November 2026; and whether the Department is able to share a...
Yes.
Specific dates for contract commencement within quarter one of 2027 will be communicated in due course.
To ask His Majesty's Government what assessment they have made of the Assessment of Veterinary Antimicrobial Residues in Feedlot Soils in Argentina, published in the scientific journal Antibiotics on 3 September; and what action, if any, they intend to take as a result.
To ask His Majesty's Government what assessment they have made of the Assessment of Veterinary Antimicrobial Residues in Feedlot Soils in Argentina, published in the scientific journal Antibiotics on 3 September; and what action, if any, they intend to take as a result.
To ask His Majesty's Government what controls are in place to assess whether antimicrobial use records, medicated feed records, and veterinary treatment records, in beef export supply chains are complete, reliable, independently audited, and capable of being traced to individual animals or batches.
To ask His Majesty's Government what controls are in place to assess whether antimicrobial use records, medicated feed records, and veterinary treatment records, in beef export supply chains are complete, reliable, independently audited, and capable of being traced to individual animals or batches.
To ask the Secretary of State for Health and Social Care, what assessment his Department and the UK Health Security Agency have made of the potential merits of promoting targeted hygiene in workplaces and public spaces as a means of reducing the spread of infectious diseases and antimicrobial resistance.
To ask the Secretary of State for Health and Social Care, what assessment his Department and the UK Health Security Agency have made of the potential merits of promoting targeted hygiene in workplaces and public spaces as a means of reducing the spread of infectious diseases and antimicrobial resistance.
The Department and the UK Health Security Agency (UKHSA) recognise that effective infection prevention and control measures play an important role in reducing the transmission of infectious diseases in workplaces, public spaces, and other community settings. Current evidence continues to support targeted, risk-based hygiene measures as an effective means of reducing the spread of infectious diseases.
The World Health Organization and UNICEF's guidelines highlight the role of hand hygiene in community environments, including public and institutional settings, and in reducing diarrhoeal disease and acute respiratory infections. These objectives are consistent with existing Government policies to prevent and control infections and support public health.
New clause 31 debated and withdrawn. New clause 32 debated and negatived on division (2 to 9). New clause 36, discussed with new clause 37, debated and withdrawn. New clause 38 debated and negatived on division (4 to 9). New clause 40 debated and negatived on division (4 to 9). New clause 41 debated and negatived on division (3 to 9). New clause 42 negatived on division (5 to 9). New clause 44 negatived on division (3 to 9). New clause 45 negatived on division (3 to 9). New clause 46, discussed with new clause 75, debated and negatived on division (5 to 9). New clause 47 debated and negatived on division (5 to 9). New clause 48, debated with new clauses 53, 54, 65 and 100, debated and negatived on division (5 to 9). New clause 49 debated and negatived on division (2 to 9). New clause 50 under consideration.
New clause 31 debated and withdrawn. New clause 32 debated and negatived on division (2 to 9). New clause 36, discussed with new clause 37, debated and withdrawn. New clause 38 debated and negatived on division (4 to 9). New clause 40 debated and negatived on division (4 to 9)....
To ask the Secretary of State for Health and Social Care, with reference to the Neighbourhood Health Framework published on 17 March, what assessment has been made of the effectiveness of the inclusion of infection diagnostics within the plan; and what steps are being taken to ensure access to rapid...
To ask the Secretary of State for Health and Social Care, with reference to the Neighbourhood Health Framework published on 17 March, what assessment has been made of the effectiveness of the inclusion of infection diagnostics within the plan; and what steps are being taken to ensure access to rapid...
The Neighbourhood Health Framework focuses on improving access to diagnostic services by bringing them closer to home as part of the wider ambition to shift care from hospital to community settings. In this context, it commits NHS England to reviewing direct access to diagnostics for general practice and undertaking a review of diagnostic services to map existing community diagnostic centre capacity and planned expansion.
Rapid and point‑of‑care infection diagnostics can play an important role in supporting clinical decision-making, antimicrobial stewardship, and more appropriate antibiotic prescribing. The Government’s approach to improving access to these technologies is informed by the UK 2024–2029 National Action Plan on antimicrobial resistance, which identifies improved diagnostics and diagnostic stewardship as key priorities in reducing unnecessary antimicrobial use. The UK 2024–2029 National Action Plan on antimicrobial resistance is available at the following link:
NHS England and local systems will continue to consider opportunities to improve access to appropriate diagnostic technologies, including rapid and point‑of‑care tests, as part of wider efforts to strengthen community diagnostic pathways. Decisions on the adoption and use of these technologies are guided by evidence on clinical effectiveness, cost-effectiveness, and operational feasibility.
To ask the Secretary of State for Health and Social Care, what his planned timetable is for the launch of the UK antimicrobial subscription model, including (a) the award and (b) commencement of contracts.
To ask the Secretary of State for Health and Social Care, what his planned timetable is for the launch of the UK antimicrobial subscription model, including (a) the award and (b) commencement of contracts.
On behalf of all the nations of the United Kingdom, NHS England published an invitation to tender for the UK subscription model for antimicrobials on 24 August 2024. The assessment of each product is being undertaken by a panel convened by the National Institute for Health and Care Excellence against the award criteria. Once that process is complete, the results will be communicated to bidders along with an award offer where appropriate.
Following the award offer, it is normal practice for a 10-day standstill period before contracts commence. Further details on timings will be available once the assessment process is complete, however, suppliers involved in the process have already been advised that contract award is likely to be in November, with contracts commencing from quarter one of 2027.
To ask the Secretary of State for Environment, Food and Rural Affairs, what assessment his department has made of the potential impact on repeated disposal of antimicrobial toilet additives from motorhomes and caravans into campsite septic tanks.
To ask the Secretary of State for Environment, Food and Rural Affairs, what assessment his department has made of the potential impact on repeated disposal of antimicrobial toilet additives from motorhomes and caravans into campsite septic tanks.
Sewage discharges are regulated by the Environmental Permitting (England and Wales) Regulations 2016. These Regulations allow lower risk discharges to operate under statutory General Binding Rules, but any discharge which cannot comply with those rules can only be made in accordance with an Environmental Permit issued by the Environment Agency. When a permit application is processed, the potential risks to the receiving environment are considered and conditions to protect the environment are applied to any permit that is issued.
If the disposal of toilet waste containing additives compromises the treatment provided by a campsite septic tank then the discharge may cause pollution, and the operator of the septic tank could be subject to enforcement action by the Environment Agency.
To ask the Secretary of State for Health and Social Care, what steps his Department is taking to ensure the adequacy of outpatient parenteral antimicrobial therapy services to patients in rural areas.
To ask the Secretary of State for Health and Social Care, what steps his Department is taking to ensure the adequacy of outpatient parenteral antimicrobial therapy services to patients in rural areas.
It is the responsibility of local commissioners and providers to ensure the adequacy of all services to patients in rural areas, and that includes Outpatient Parenteral Antimicrobial Therapy (OPAT).
In 2022, NHS England surveyed OPAT provision across England, and that report is available to health and social care workers on FutureNHS. As part of the Antimicrobial Resistance National Action Plan 2024-2029, NHS England plans to repeat that survey to assess the impact of the guidance on OPAT provision.
We also note that to support those who are planning to develop OPAT services, including for rural areas, NHS England published guidance on developing OPAT services to integrated care boards and providers in 2025.
To ask the Secretary of State for Environment, Food and Rural Affairs, with reference to her Department's document entitled Guidelines and guidance on the responsible use of veterinary medicines, updated on 8 October 2024, what assessment she has made of the potential impact of the inclusion of blanket flea and...
To ask the Secretary of State for Environment, Food and Rural Affairs, with reference to her Department's document entitled Guidelines and guidance on the responsible use of veterinary medicines, updated on 8 October 2024, what assessment she has made of the potential impact of the inclusion of blanket flea and...
Flea and tick products play an important role in protecting animal and human health; however, the Veterinary Medicines Directorate (VMD) recognises increasing concerns about the environmental impacts of substances such as fipronil and imidacloprid. Monitoring in England has detected these substances in some watercourses at levels that may pose a risk to aquatic invertebrates.
The VMD is leading cross‑government work through the Pharmaceuticals in the Environment Group to support responsible use of these products. Recently published VMD‑funded studies (2024–25) have shown that spot‑on flea and tick products can contribute to environmental levels of imidacloprid and fipronil through wastewater pathways and when dogs swim. These findings strengthen the evidence base, but important gaps remain, including understanding the potential unintended consequences if usage patterns change. This is being considered as part of wider stewardship work to ensure future decisions remain proportionate, evidence based and protective of animal welfare.
Antimicrobial resistance (AMR) is a significant threat to public health. This briefing provides information on the causes and implications of the development and spread of AMR and UK action to address it.
Antimicrobial resistance (AMR) is a significant threat to public health. This briefing provides information on the causes and implications of the development and spread of AMR and UK action to address it.
To ask His Majesty's Government what plans they have to mitigate the effects in Northern Ireland of a potential EU ban on the sale of antimicrobial drugs without prescription.
To ask His Majesty's Government what plans they have to mitigate the effects in Northern Ireland of a potential EU ban on the sale of antimicrobial drugs without prescription.
The EU has not yet formally approved or published a final legal text, I am however aware of the potential impacts of restrictions on the sale of antimicrobial medicines without prescription on Northern Ireland's health services, particularly demand for GP appointments. The Government has raised this issue and we will, as ever, always advocate for the interests of Northern Ireland.
The Government will publish an explanatory memorandum in due course in accordance with the usual processes.
My hon Friend the Minister of State (Chris Bryant MP) has today made the following statement.
The United Kingdom and the Republic of Korea (RoK) have concluded negotiations on an upgraded Free Trade Agreement (FTA). Building on the work of the previous Secretary of State for Business and Trade, and Minister...
My hon Friend the Minister of State (Chris Bryant MP) has today made the following statement.
The United Kingdom and the Republic of Korea (RoK) have concluded negotiations on an upgraded Free Trade Agreement (FTA). Building on the work of the previous Secretary of State for Business and Trade, and Minister...
The United Kingdom and the Republic of Korea (RoK) have concluded negotiations on an upgraded Free Trade Agreement (FTA). Building on the work of the previous Secretary of State for Business and Trade, and Minister of State for Trade Policy and Economic Security, the new FTA builds on our existing...
The United Kingdom and the Republic of Korea (RoK) have concluded negotiations on an upgraded Free Trade Agreement (FTA). Building on the work of the previous Secretary of State for Business and Trade, and Minister of State for Trade Policy and Economic Security, the new FTA builds on our existing...
That this House recognises and marks World Antimicrobial Resistance Awareness Week 2025; notes that the theme this year is Act Now: Protect Our Present, Secure Our Future and urges bold, united action; further notes that antimicrobial resistance (AMR) contributes to an estimated 35,200 deaths annually in the UK, with drug-resistant infections in humans rising by 13 per cent despite a target to reduce them by 10 per cent; acknowledges that, in England, 1 in 5 hospital beds are occupied by patients with infectious diseases, and those with resistant infections are more likely to die within 30 days than those with treatable infections; further recognises that it is estimated that AMR globally contributes to $412 billion a year in healthcare expenditure; also notes that infection diagnostic tests are advancing rapidly, particularly since the covid-19 pandemic and the rapid development of lateral flow tests and point-of-care technology; notes that early evidence shows that some newer infection diagnostic tests can have cost-saving benefits of over £8,000 per test and that smarter infection diagnostics, from rapid tools in GP surgeries to advanced hospital-based susceptibility tests, are central to delivering optimal infection care, enabling earlier interventions, targeted treatments, and more efficient use of NHS capacity; believes that despite their clinical and economic value, these tools remain underused; and further believes that it is imperative that findings from recent research are harnessed and that the Government must invest in infection diagnostics in the NHS.
That this House recognises and marks World Antimicrobial Resistance Awareness Week 2025; notes that the theme this year is Act Now: Protect Our Present, Secure Our Future and urges bold, united action; further notes that antimicrobial resistance (AMR) contributes to an estimated 35,200 deaths annually in the UK, with drug-resistant...
Lords motion to consider. Agreed to on question.
Lords motion to consider. Agreed to on question.
My Lords, these draft regulations were laid before the House on 16 September. I welcome the chance to set out the action that this Government and the devolved Governments are taking to ban the supply and sale of wet wipes containing plastic right across the UK.
The Government are committed to...
My Lords, these draft regulations were laid before the House on 16 September. I welcome the chance to set out the action that this Government and the devolved Governments are taking to ban the supply and sale of wet wipes containing plastic right across the UK.
The Government are committed to...
I thank the Minister for introducing this instrument proposing the ban on the supply and sale of wet wipes. There is no doubt that there is a significant and ongoing problem with wet wipes, and I agree that urgent action is needed to ban the sale and supply of wet...
I thank the Minister for introducing this instrument proposing the ban on the supply and sale of wet wipes. There is no doubt that there is a significant and ongoing problem with wet wipes, and I agree that urgent action is needed to ban the sale and supply of wet...
I am delighted to see these regulations, but I agree with my noble friend Lady Redfern that it is sad to see that they will not come into effect until May 2027 at the earliest. It has been a while since the original consultation happened. To give a bit of...
I am delighted to see these regulations, but I agree with my noble friend Lady Redfern that it is sad to see that they will not come into effect until May 2027 at the earliest. It has been a while since the original consultation happened. To give a bit of...